ASTH · Astrana Health Inc
United States · RS rating 65 · As of 2026-10-14
| Price | 37.72 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 55 / 23 / 81 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 44 / 64 / 49 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +141.7% |
| Sales growth Q/Q | -0.6% |
| Distance from 52-week high | +24.3% |
| Market cap (USD) | $1.8B |